These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 7868402

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mechanisms of quinolone resistance in clinical isolates: accumulation of sparfloxacin and of fluoroquinolones of various hydrophobicity, and analysis of membrane composition.
    Denis A, Moreau NJ.
    J Antimicrob Chemother; 1993 Sep; 32(3):379-92. PubMed ID: 8262860
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Routes of quinolone permeation in Escherichia coli.
    Chapman JS, Georgopapadakou NH.
    Antimicrob Agents Chemother; 1988 Apr; 32(4):438-42. PubMed ID: 3132091
    [Abstract] [Full Text] [Related]

  • 6. Ciprofloxacin affects conformational equilibria of DNA gyrase A in the presence of magnesium ions.
    Sissi C, Perdonà E, Domenici E, Feriani A, Howells AJ, Maxwell A, Palumbo M.
    J Mol Biol; 2001 Aug 03; 311(1):195-203. PubMed ID: 11469868
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of the mechanism of action and resistance of two new fluoroquinolones, rufloxacin and MF961 with those of ofloxacin and fleroxacin in gram-negative and gram-positive bacteria.
    Piddock LJ, Panchal S, Norte V.
    J Antimicrob Chemother; 1993 Jun 03; 31(6):855-63. PubMed ID: 8395493
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H, Hayakawa I, Akimoto T.
    Yakushigaku Zasshi; 2003 Jun 03; 38(2):161-79. PubMed ID: 15143768
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Quinolone antimicrobial agents: mechanism of action and resistance development.
    Bryan LE, Bedard J, Wong S, Chamberland S.
    Clin Invest Med; 1989 Feb 03; 12(1):14-9. PubMed ID: 2537696
    [Abstract] [Full Text] [Related]

  • 16. Quinolones sensitize gram-negative bacteria to antimicrobial peptides.
    Campos MA, Morey P, Bengoechea JA.
    Antimicrob Agents Chemother; 2006 Jul 03; 50(7):2361-7. PubMed ID: 16801413
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of divalent metal cations in the growth medium upon sensitivity of batch-grown Pseudomonas aeruginosa to EDTA or polymyxin B.
    Boggis W, Kenward MA, Brown MR.
    J Appl Bacteriol; 1979 Dec 03; 47(3):477-88. PubMed ID: 44290
    [No Abstract] [Full Text] [Related]

  • 19. Conditions affecting the results of susceptibility testing for the quinolone compounds.
    Smith SM, Eng RH, Cherubin CE.
    Chemotherapy; 1988 Dec 03; 34(4):308-14. PubMed ID: 3208548
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.